Skip to main content

Table 1 Participant characteristics

From: Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy

 

MPH (n = 16)

ATX (n = 14)

p value

Mean

SD

Mean

SD

Sex (male/female)a

14/2

 

11/3

 

0.642

Age (years)

8.19

2.46

9.50

2.03

0.125

Medication dose (mg/kg)

0.87

0.23

1.30

0.44

NA

FIQ (WISC-IV)

94.19

13.46

96.64

14.43

0.634

ARF

30.63

10.65

32.29

13.46

0.709

ARI

16.75

5.52

18.29

6.84

0.502

ARH

13.88

6.72

14.00

7.99

0.963

SCWC-1

18.31

7.66

25.86

8.76

0.018

SCWC-2

19.81

9.56

29.36

11.11

0.017

SCWC-3

21.19

9.17

25.36

10.35

0.252

  1. MPH methylphenidate, ATX atomoxetine, NA not applicable, FIQ full-scale IQ, WISC-IV Wechsler Intelligence Scale for children-fourth edition, ARF ADHD RS IV-J full scores, ARI ADHD RS IV-J inattention subscale scores, ARH ADHD RS IV-J hyperactivity subscale scores, SCWC-1 Stroop color-word task number of correct answers first time, SCWC-2 Stroop color-word task number of correct answers second time, SCWC-3 Stroop color-word task number of correct answers third time
  2. aThe Chi square test was used; otherwise t-tests were used
Back to article page

Child and Adolescent Psychiatry and Mental Health

ISSN: 1753-2000